Tetrachloroethylene

Tetrachloroethylene

SCHEMBL4639552

Cl.ClC(Cl)=C(Cl)Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Tetrachloroethylene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0726888-A1 PROCESS FOR MANUFACTURE OF HIGH PURITY 1,1-DICHLOROTETRAFLUOROETHANE E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-08-21 EP claimed
US-5545770-A CONTACTING MIXTURE OF PERHALOGENATED HYDROCARBONS WITH HYDROGEN FLUORIDE OVER FLUORINATION CATALYST AT ELEVATED TEMPERATURE, RECOVERING PRODUCT, ISOMERIZING AND RECYCLING TRICHLOROTRIFLUOROETHANE PRODUCED E.I. DU PONT DE NEMOURS AND COMPANY (US) 1996-08-13 US claimed
US-5446216-A Catalytic halogenation, isomerization E. I. DU PONT DE NEMOURS AND COMPANY (US) 1995-08-29 US claimed
WO-1995012566-A1 PROCESS FOR MANUFACTURE OF HIGH PURITY 1,1-DICHLOROTETRAFLUOROETHANE E.I. DU PONT DE NEMOURS AND COMPANY (US) 1995-05-11 WO claimed
CN-112996387-A Aqueous solutions of poorly soluble active ingredients using polyalkoxylated aminoalcohols 陶氏环球技术有限责任公司 2021-06-18 CN disclosed
CN-106631679-B Produce the improvement technique of the chloro- 1.2.2- trifluoroethane of 1.1.2- tri- 浙江埃克盛化工有限公司 2019-11-19 CN disclosed
CN-109456143-A The purification process of tetrachloro-ethylene 郑州师范学院 2019-03-12 CN disclosed
CN-104001534-B A kind of catalyst of the de- HCl tetrachloro-ethylenes of pentachloroethane catalysis and preparation method thereof 江苏理文化工有限公司 2017-07-07 CN disclosed
CN-104001534-B A kind of catalyst of the de- HCl tetrachloro-ethylenes of pentachloroethane catalysis and preparation method thereof 江苏理文化工有限公司 2017-07-07 CN disclosed
CN-106631679-A Improved technology for producing 1,1,2-trichloro-1,2,2-trifluoroethane 浙江埃克盛化工有限公司 2017-05-10 CN disclosed
CN-106475084-A A kind of non-metallic catalyst and its application in gas phase catalysis tetrachloro-ethylene 中国科学院上海高等研究院 2017-03-08 CN disclosed
CN-205683808-U Three grades of absorption systems of hydrochloric acid in tetrachloroethylene production 重庆天原化工有限公司 2016-11-16 CN disclosed
CN-104001534-A Catalyst for preparing perchloroethylene by catalyzing pentachloroethane to remove HCl and preparation method thereof JIANGSU LEE & MAN CHEMICAL LTD 2014-08-27 CN disclosed
EP-1951949-A1 MULTIFUNCTIONAL FILTER AND PROCESS FOR USING THE SAME TO TREAT LIPOPHILIC FLUID The Procter and Gamble Company (US) 2008-08-06 EP disclosed
US-20070099809-A1 Dry cleaning system and process PROCTER & GAMBLE COMPANY, THE 2007-05-03 US disclosed
WO-2007049252-A2 DRY CLEANING SYSTEM AND PROCESS THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 WO disclosed
WO-2007049161-A1 MULTIFUNCTIONAL FILTER AND PROCESS FOR USING THE SAME TO TREAT LIPOPHILIC FLUID THE PROCTER & GAMBLE COMPANY (US) 2007-05-03 WO disclosed
US-20070012616-A1 Multifunctional filter and process for using the same to treat lipophilic fluid PROCTER & GAMBLE COMPANY, THE 2007-01-18 US disclosed
US-4147556-A Nonflammable beta diketonate composition PPG INDUSTRIES, INC. (US) 1979-04-03 US disclosed